The possible role of sphingosine‐1‐phosphate in 50‐Hz magnetic field‐induced cell proliferation of human amniotic cells should be investigated.
Cells were either exposed or sham exposed. In some tests, cells were tested under addition of SKI II, an inhibitor of sphingosine kinase, or U0126, an inhibitor of ERK 1 and 2.
Exposure | Parameters |
---|---|
Exposure 1:
50 Hz
Exposure duration:
60 min
|
|
Frequency | 50 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | 60 min |
Exposure source | |
---|---|
Chamber | two exposure chambers which were put in a CO2 incubator |
Setup | one chamber was used for exposure and the other for sham exposure; each chamber consisted of a set of square Helmholtz coils (20 × 20 cm2), which was encased by mu‐metal for shielding the cells placed in the coils from stray magnetic fields; a fan on the metal wall ensured the air and the temperature was uniform between inside the chamber and incubator; during exposure, cell dishes were put in the center of the chambers; the temperature in the chambers was kept at 37.0 ± 0.2°C throughout the whole exposure period; the difference of the temperature between exposure and sham exposure conditions during the entire exposure period did not exceed 0.1°C |
Sham exposure | A sham exposure was conducted. |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 0.4 mT | - | - | - | - |
Exposure to the magnetic field increased cell proliferation, enhanced levels of ceramides and sphingosin-1-phosphate and activated ERK 1/2 significantly compared to the sham exposure.
The increase in cell proliferation and ERK1/2 activation was inhibited by the sphingosine kinase inhibitor SKI II and the inhibitor of ERK 1 and 2, U0126.
The authors conclude that sphingosine‐1‐phosphate could mediate 50‐Hz magnetic field‐induced cell proliferation of human amniotic cells via triggering the ERK1/2 signal pathway.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.